The test makes it possible to detect whether the father or mother are carriers of a disease of genetic origin and thereby reduce the risk of passing on that disease to their future children.
- More than 300 inherited genetic diseases can be detected
- The test can identify up to 2,600 chromosomal mutations
- The analysis is carried out by a simple blood or saliva test
At Eugin, we are not just concerned about helping future mums to get pregnant; we are also concerned about the health of the child who is going to be born. For this reason, we offer all our patients the chance to undergo the Genetic Compatibility Test before starting their treatment.
What is a genetic compatibility test?
The Genetic Compatibility Test is a blood or saliva DNA study of the future parents, which allows us to detect whether the man or the woman are carriers of a genetic disease and can therefore pass it on to their children.
According to our experience, practically 1 in 2 patients undergoing the test at Eugin is a carrier of a hereditary genetic disease without knowing it – which means that even though they carry the disease, they will not actually develop it.
When both members of the couple are carriers of the same disease, there is a 25% chance that their child will develop it.
The Genetic Compatibility Test enables us to detect whether this situation can occur by identifying more than 300 genetic diseases with a poor prognosis in children, such as cystic fibrosis, fragile X syndrome or spinal muscular atrophy, among many others.
The test is a preventive measure that is performed before starting the fertility treatment in order to determine whether the future father or future mother are carriers of any of these diseases. Through this test, it is possible to determine and prevent the risk of the child developing any of these 300 genetic diseases.
Who is it intended for?
The Genetic Compatibility Test is aimed at all patients who are going to undergo fertility treatment.
What happens with the information obtained?
The result of the test will be available three to four weeks after the blood or saliva test, which is when the doctor will share it with the patients.
In cases in which there is a risk of passing on genetic diseases to future children, the doctor will indicate to patients what their best option is in accordance with the available assisted reproduction procedures.